Hong Liu to Drug Administration Schedule
This is a "connection" page, showing publications Hong Liu has written about Drug Administration Schedule.
Connection Strength
0.013
-
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients. Cancer Invest. 2003; 21(4):542-9.
Score: 0.013
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.